The American Lung Association
Major Sponsors Saturday
Charleston, WV 25301
415 Dickinson St.
in West Virginia
September 26, 2009
University of Charleston
CSL Behring School of Pharmacy
Supported by an educational grant from
Talecris Biotherapeutics, Center for
Science and Education.
The West Virginia University School of
Pharmacy (WVSoP) is accredited by the A one-day knowledge based
Accreditation Council for Pharmacy Education conference for patients with lung
(ACPE). This program (ACPE# 072-999-09-091 to
95) is approved for pharmacists up to a total of disease and the healthcare
5.75 hours (5.75 CEU’s) of continuing pharmacy
education credit. A statement of credit will be professionals who provide their
mailed by the WVUSoP Office of Continuing care.
Education within two to four weeks of the pro-
gram to participants who successfully complete
the program. Successful completion includes
attending the entire session, signing the atten-
dance sheet, and completing an evaluation Continuing Education Credits for
form. Pharmacists, Registered Nurses, and
The American Lung Association is a registered
provider for continuing education credits with
the West Virginia Board of Respiratory Care
Permit No. 125
(Provider number BORC 02-04-042) and the
West Virginia Board of Examiners for Registered
Professional Nurses (Provider number WV97-
9am-10am Registration • Identify prognostic factors in determining diseases of importance in the
outcome in COPD. Appalachian Region.
9:45am-10:45am Sleep Apnea Update • Discuss the special features of alpha-1 • Compile a list of ‘best practices’ to be
and Management- Mahendra Patel, MD antitrypsin deficiency related COPD. used by health team members with
FCCP Director, Saint Francis Hospital their patients and in their community to
Sleep Center, Charleston, WV ACPE# 072- 1:45pm-3:00pm Lung Cancer 2009: mitigate diseases arising from these
999-09-091-L01-P Recognition and Therapies- John E. Parker, environmental and occupational
• Discuss sleep apnea prevalence. MD– Professor and Chief, Pulmonary and
• Examine public health approaches that
• Outline salient clinical features. Critical Care Medicine, West Virginia
can primarily or secondarily prevent
• Describe systemic effects of obstructive University, Morgantown, WV ACPE# 072-999-09
disease arising from these occupational
sleep apnea (OSA). -094-L01-P
and environmental exposures.
• Identify reasons for continuous positive • Identify the major causes of lung cancer.
airway pressure (CPAP) non-compliance. • Outline an approach to the diagnosis of
lung cancer. Register
10:45am-11:45am The Asthma Epidemic: • Explain the complications of lung cancer.
Are You Prepared?- Len Picha, RRT • List important therapies for lung cancer. Admission is $30
Charleston Area Medical Center, • State the various palliative approaches to
bronchial obstruction in lung cancer. Name_____________________________
Charleston, WV ACPE# 072-999-09-092-L04-P
• Identify the prevalence of Asthma in West • Describe treatments for malignant pleural Organization______________________
• Discuss the essential components in Address___________________________
building a successful asthma program. 3:15pm-4:30pm Epidemiologic Update on ___________________________________
• Discuss how community partnerships and Environmental and Occupational
networking support asthma programs. Pulmonary Exposures of Concern to West Phone____________________________
Virginians and a Review of Key Prevention Email_____________________________
11:45am– 12:30pm Lunch and Treatment Strategies for the Health
Professional Team– Edward J. Doyle, Jr. MD, Credit Card_______________________
12:30pm-1:45pm Chronic Obstructive MS- Professor Emeritus of Community Exp. Date______________
Pulmonary Disease (COPD) and Alpha-1- Medicine, West Virginia University,
Edward Eden, MD– Chief, Division of Morgantown, WV ACPE# 072-999-09-095-L04-P _____I have included cash/check.
Pulmonary Critical Care and Sleep • Explain anatomy of the lungs and the Remit to:
Medicine, St Luke's Roosevelt Hospital toxicology of select agents in producing
American Lung Association in WV
Center. Associate Professor of Clinical disease.
Medicine at Columbia University, New • Describe the methodology, conclusions, 415 Dickinson St.
York, NY. ACPE# 072-999-09-093-L01-P and weaknesses of recent epidemiologic Charleston, WV 25301
• Identify risk factors and mechanisms for studies that have expanded our studies that Phone: 304. 342.6600
the development of COPD. have expanded our awareness of diseases Fax: 304.342.6600
Describe the effectiveness of current associated with mineral, particulate, fume,
and gas pulmonary exposure related
treatments for COPD.